Aveanna Healthcare (AVAH) Jefferies Global Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
Jefferies Global Healthcare Conference summary
1 Feb, 2026Strategic transformation and operational momentum
Entering year two of a strategic transformation, focusing on accelerating preferred payer and government affairs strategies.
2023 focused on stabilizing revenue, earnings, and defining a preferred payer approach.
2024 emphasizes shifting caregiver capacity to payers offering enhanced rates and value-based models.
Recent quarters have seen strong performance, with beat-and-raise results and positive momentum.
Free cash flow generation and capital structure improvements are key priorities.
Rate increases and government affairs
Targeting 6–10 Medicaid states annually for material rate increases, aiming for 8–12 per year long-term.
Recent wins include a 34% rate increase in Georgia, with similar efforts ongoing in California and Massachusetts.
Rate increases enable improved staffing, business growth, and higher fill rates, especially in underfunded states.
Most incremental rate is passed through to caregivers, boosting recruitment and retention.
Legislative cycles and advocacy are central to achieving these rate improvements.
Growth, fill rates, and preferred payer strategy
PDS segment volume growth has accelerated to 3–4%, expected to normalize at 3–5% after 1–2 years.
Fill rates for preferred payers now reach 90%, up from 40–50% during COVID, with non-preferred payers lagging.
Recruitment responds rapidly to wage increases, with job postings and transparency aiding hiring.
Value-based agreements allow for additional bonuses by meeting performance metrics.
Execution of the preferred payer strategy is key to sustaining growth and operational efficiency.
Latest events from Aveanna Healthcare
- Q2 revenue up 7% to $505M, adjusted EBITDA up 27%, guidance raised despite lower net income.AVAH
Q2 20242 Feb 2026 - Strategic transformation and rate wins drive growth, staffing, and margin expansion in 2024.AVAH
Healthcare Services Conference1 Feb 2026 - 2025 guidance raised as transformation and Q3 results drive scalable, value-based growth.AVAH
44th Annual J.P. Morgan Healthcare Conference16 Jan 2026 - Q3 revenue up 6.5%, adjusted EBITDA rose 32.2%, and guidance was raised for 2024.AVAH
Q3 202416 Jan 2026 - Strategic transformation and efficiency drive growth, margin expansion, and strong cash flow.AVAH
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - Strong 2024 revenue and margin gains, with 2025 guidance signaling further growth.AVAH
Q4 202424 Dec 2025 - Registering $400M in securities and 54M+ shares for resale, targeting home care growth.AVAH
Registration Filing16 Dec 2025 - Shelf registration allows ongoing securities offerings with strong board protections.AVAH
Registration Filing16 Dec 2025 - Double-digit growth driven by scale, payer partnerships, and disciplined expansion.AVAH
Bank of America Home Care Conference9 Dec 2025